Vetoquinol: Availability of the 2020 Universal Registration Document
28 April 2021 - 6:00PM
Business Wire
Regulatory News:
Vetoquinol (Paris:VETO) informs that it has filed its 2020
Universal Registration Document with the Autorité des Marchés
Financiers (AMF) on April 28th, 2021.
The 2020 Universal Registration Document is available to the
public, free of charge under the conditions provided by applicable
regulations and may be consulted on the “Investors” page of the
Group’s website (www.vetoquinol.com), in the “Regulated
Information” section. It is also available on the AMF’s website
(www.amf-france.org).
The 20202 Universal Registration Document includes:
- the 2020 Annual Financial Report;
- the Management Report;
- the Board of Directors Report on Corporate Governance;
- the Extra-Financial Performance Declaration;
- the information related to the fees paid to the Statutory
Auditors;
- the share buyback program description; and
- the agenda and draft resolutions of the Shareholder’s Meeting
of May 27th, 2021.
Next update: Shareholders’ meeting, May 27th, 2021
ABOUT VETOQUINOL Vetoquinol is a leading global animal health
company that supplies drugs and non-medicinal products for the
livestock (cattle and pigs) and pet (dogs and cats) markets. As an
independent pure player, Vetoquinol designs, develops and sells
veterinary drugs and non-medicinal products in Europe, the Americas
and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has been pursuing a strategy combining innovation with
geographical diversification. The Group's hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. At December 31st
2020, Vetoquinol employs 2,409 people. Vetoquinol has been listed
on Euronext Paris since 2006 (symbol: VETO).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005758/en/
VETOQUINOL
Investor Relations Fanny Toillon Tel.: +33 (0)3 84
62 59 88 relations.investisseurs@vetoquinol.com
KEIMA COMMUNICATION
Investor & Media Relations Emmanuel Dovergne
Tel.: +33 (0) 1 56 43 44 63 emmanuel.dovergne@keima.fr
Vetoquinol (EU:VETO)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Vetoquinol (EU:VETO)
Historical Stock Chart
Von Apr 2023 bis Apr 2024